Dr. Zabeti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3113 Bellevue Ave
Fl 3
Cincinnati, OH 45219Phone+1 513-475-8730Fax+1 513-475-8033
Education & Training
- Oregon Health & Science UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
- West Virginia UniversityResidency, Neurology, 2009 - 2012
- West Virginia UniversityInternship, Transitional Year, 2008 - 2009
- Azad UniversityClass of 1999
Certifications & Licensure
- OR State Medical License 2012 - Present
- CA State Medical License 2017 - 2025
- KY State Medical License 2015 - 2025
- OH State Medical License 2013 - 2025
- WV State Medical License 2011 - 2013
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 173 citationsPhase 2 trial of ibudilast in progressive multiple sclerosisRobert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason
The New England Journal of Medicine. 2018-08-30 - 29 citationsIdentification of proteins in human substantia nigraEfstathia Kitsou, Sheng Pan, Jian Peng Zhang, Min Shi, Aram Zabeti
Proteomics. Clinical Applications. 2008-05-01 - 12 citationsWorldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.Sara Bagherieh, Alireza Afshari-Safavi, Saeed Vaheb, Mahsa Kiani, Elham Moases Ghaffary
Neurological Sciences. 2023-06-01
Journal Articles
- Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisAram Zabeti, MD, The New England Journal of Medicine
Press Mentions
- Cincinnati Plays Role in Breakthrough Multiple Sclerosis StudyAugust 30th, 2018
- Multiple Sclerosis Drug Slows Brain Shrinkage, Study ShowsAugust 29th, 2018
- Strikeout MS Founders Present $25,000 to UC's Waddell CenterApril 20th, 2018
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: